RLYBNasdaq United States
Market cap
$85.618 M
$16.16 -0.18%
Close of 7 Aug 2026
Revenue
$858.0K
#3512 by revenue
Earnings
-$8.98M
Loss-making
Shares outstanding
5,310,499
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Rallybio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.